Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
12.61
-0.15 (-1.18%)
Sep 11, 2026, 3:04 PM CST
SHE:300122 Revenue
Chongqing Zhifei Biological Products had revenue of 1.87B CNY in the quarter ending June 30, 2026, a decrease of -27.24%. This brings the company's revenue in the last twelve months to 8.05B, down -36.68% year-over-year. In the year 2025, Chongqing Zhifei Biological Products had annual revenue of 8.96B, down -65.61%.
Revenue (ttm)
8.05B
Revenue Growth
-36.68%
P/S Ratio
3.79
Revenue / Employee
1.28M
Employees
6,292
Market Cap
30.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.96B | -17.09B | -65.61% |
| Dec 31, 2024 | 26.05B | -26.87B | -50.77% |
| Dec 31, 2023 | 52.92B | 14.65B | 38.30% |
| Jan 1, 2023 | 38.26B | 7.61B | 24.83% |
| Dec 31, 2021 | 30.65B | 15.46B | 101.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsChongqing Zhifei Biological Products News
- 14 days ago - Chongqing Zhifei Biological Products Quarterly report: Q2 2026 - Filings
- 4 months ago - Chongqing Zhifei Biological Products Annual report: Q4 2025 - Filings
- 4 months ago - Chongqing Zhifei Biological Products Quarterly report: Q1 2026 - Filings
- 10 months ago - Chongqing Zhifei Biological Products Quarterly report: Q3 2025 - Filings